News
Ann Wojcicki's TTAM to Acquire 23andMe for $305M
Digest more
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback